acetazolamide has been researched along with Retinal Degeneration in 3 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report on the efficacy of the oral carbonic anhydrase inhibitor (CAI) acetazolamide in treating macular retinoschisis (RS) in the rare vitreoretinal dystrophy best known as the enhanced S-cone syndrome (ESCS)." | 7.75 | Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. ( Eyestone, ME; Fung, KH; Iannaccone, A; Stone, EM, 2009) |
| "To report on the efficacy of the oral carbonic anhydrase inhibitor (CAI) acetazolamide in treating macular retinoschisis (RS) in the rare vitreoretinal dystrophy best known as the enhanced S-cone syndrome (ESCS)." | 3.75 | Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. ( Eyestone, ME; Fung, KH; Iannaccone, A; Stone, EM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iannaccone, A | 1 |
| Fung, KH | 1 |
| Eyestone, ME | 1 |
| Stone, EM | 1 |
| Stanga, PE | 1 |
| Downes, SM | 1 |
| Ahuja, RM | 1 |
| Chong, NH | 1 |
| Antcliff, R | 1 |
| Reck, AC | 1 |
| Bird, AC | 1 |
| Kornzweig, AL | 1 |
3 other studies available for acetazolamide and Retinal Degeneration
| Article | Year |
|---|---|
Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide.
Topics: Acetazolamide; Acute Disease; Administration, Oral; Carbonic Anhydrase Inhibitors; Electroretinograp | 2009 |
Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Female; Fluorescein Angio | 2001 |
Diagnosis and treatment of common eye diseases in the aged: guidelines for the practicing physician.
Topics: Acetazolamide; Age Factors; Aged; Cataract; Cataract Extraction; Cholinesterase Inhibitors; Diabetes | 1973 |